MRC1 and cancer: The positive expression rate of CD86 was 50% in cancer tissues and 20% in adjacent tissues, while that of CD206 in cancer tissues was 78.3% and that in adjacent tissues was 41.7%, presenting significant differences, as shown in Fig. 4.